Ori Spotlight Podcast
1) Ken Harris: Why AI and automation are CGT’s next inflection point
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Ken Harris, CEO of Omnia Bio and former Head of Precision Medicine at Amazon, to explore what it will take to scale CAR-T from hu...Show More
2) Joe DePinto: Why advanced therapies need a new delivery model
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Joe DePinto, Head of Cell and Gene Advanced Therapies at McKesson, to explore how advanced therapies can be delivered through the...Show More
3) Jonathan Gluck: A personal account of navigating myeloma and CAR-T therapy
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Jonathan Gluck, an award-winning journalist and author of An Exercise in Uncertainty, for a deeply personal conversation about il...Show More
Jonathan Gluck: A personal account of navigating myeloma and CAR-T therapy
55:35 | Dec 16th, 2025
4) John Khoury: The CGT developers who adapt new manufacturing techniques early will lead later
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes John Khoury, Founder of Project Farma, to unpack how the standards for advanced therapies are shifting.John reflects on why infra...Show More
5) Warner Biddle: Building a commercial model for CAR-T in autoimmune care
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Warner Biddle, CEO of Kyverna Therapeutics, to explore how autologous CAR-T therapies can be delivered safely, efficiently, and a...Show More
6) Lavakumar Karyampudi: Building early-phase CGT infrastructure for translational success
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Lavakumar (Kumar) Karyampudi, Senior Director of Cell Therapies at Moffitt Cancer Center, to discuss how academic institutions ar...Show More
Lavakumar Karyampudi: Building early-phase CGT infrastructure for translational success
1:00:07 | Aug 12th, 2025
7) Henrik Andersen: How smart planning helps CGT scale further, faster
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Henrik Andersen, former SVP and Head of Cell Therapy Technology Development at Bristol Myers Squibb, to explore how early plannin...Show More
8) Arsalan Arif: Investor confidence in advanced therapies is critical for long-term success
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Arsalan Arif, founder of Endpoints News, for a wide-ranging conversation on the business of biotech. From his early days bootstra...Show More
9) Julie Allickson: How early automation strategies reduce costs and improve patient access
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Dr. Julie Allickson, Chief Technology Officer for Mayo Clinic's Center for Regenerative Biotherapeutics. With over 30 years pione...Show More
10) Aaron Vernon: Designing scalable cell therapy manufacturing from day one (part 2)
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes back Aaron Vernon, Chief Manufacturing Officer at Quell Therapeutics, for the second part of the discussion on building robust an...Show More